Pharmacokinetics and pharmacodynamics of bumetanide in critically ill pediatric patients

Journal of Clinical Pharmacology

Volumn 38, Issue 11, 1998, Pages 994-1002

  Marshall, James D ^a,b   Wells, Thomas G ^c   Letzig, Lynda ^c   Kearns, Gregory L ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SCREENING; EDEMA; HUMAN; INFANT; PHARMACODYNAMICS; PROSPECTIVE STUDY;

EID: 0031726154     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127009803801102     Document Type: Article

References (37)

1. Wells TG: The pharmacology and therapeutics of diuretics in the pediatric patient. Pediatr Clin North Am 1990;37:463-504.
2. Walker PC, Shankaran S: The bilirubin-displacing capacity of bumetanide in critically ill neonates. Dev Pharmacol Ther 1988; 11:265-272.
3. Brater DC: Clinical pharmacology of loop diuretics. Drugs 1991;41(Suppl 3):14-22.
4. Voelker JR, Cartwright-Brown D, Anderson S, Leinfelder J, Sica DA, Kokko JP, Brater DC: Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int 1987;32:572-578.
5. Ryback LP: Ototoxicity of loop diuretics. Otolaryngol Clin North Am 1993;26:829-844.
6. Ward A, Heel RC: Bumetanide: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984;28:426-464.
7. Lau HSH, Hyneck ML, Berardi RR, Swartz RD, Smith DE: Kinetics, dynamics and bioavailability of bumetanide in healthy subjects and patients with renal failure. Clin Pharmacol Ther 1986;39:635-645.
8. Cook JA, Smith DE, Cornish LA, Tankanow RM, Nicklas JM, Hyneck ML: Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure. Clin Pharmacol Ther 1988;44:487-500.
9. Ward OC, Lam LKT: Bumetanide in heart failure in infancy. Arch Dis Child 1977;52:877-882.
10. Wells TG, Fasules JW, Taylor BJ, Kearns GL: Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1992;121: 974-980.
11. Shankaran S, Liang K, Hagan N, Fleischmann L: Mineral excretion following furosemide compared with bumetanide therapy in premature infants. Pediatr Nephrol 1995;9:159-162.
12. Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL: Doseranging evaluation of bumetanide pharmacodynamics in critically ill infants. Clin Pharmacol Ther 1996;60:424-434.
13. Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL: Analysis of the variability in the pharmacokinetics and pharmacodynamics of bumetanide in critically ill infants. Clin Pharmacol Ther 1996;60:414-423.
14. Sullivan JE, Witte MK, Yamashita TS, Myers CM, Blumer JL: Pharmacokinetics of bumetanide in critically ill infants. Clin Pharmacol Ther 1996;60:405-413.
15. Gehan EA, George SL: Estimation of human body surface area from height and weight. Cancer Chemother 1970;54:225-235.
16. National Heart, Lung, and Blood Institute Task Force on Blood Pressure Control in Children: Report of the Second Task Force on Blood Pressure Control in Children, 1987. Pediatrics 1987;79:1-25.
17. Park MK, Lee DH: Normative arm and calf blood pressure values in the newborn. Pediatrics 1989;83:240-243.
18. Young D: Effect of Preanalytic Variables in Clinical Lab Tests. Washington, DC: AACL Press, 1997.
19. Wells TG, Hendry IR, Kearns GL: Measurement of bumetanide in plasma and urine by high-performance liquid chromatography and application to bumetanide disposition. J Chromatogr 1991; 570:235-242.
20. Gomeni R, Gomeni C: AUTOMOD: a polyalgorithm for an integrated analysis of linear pharmacokinetic models. Comput Biol Med 1979;9:38-48.
21. Marquardt DW: An algorithm for least-squares estimation of nonlinear parameters. J Soc Indust Appl Math 1963;11:431-441.
22. Daniel C, Wood FS: Fitting Equations to Data. New York: Wiley-Interscience, 1971.
23. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criteria in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-173.
24. Wagner JG: Linear pharmacokinetic equations allowing direct calculation of needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to data. J Pharmacokinet Biopharm 1976;4:443-467.
25. Fuseau E, Sheiner LB: Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model. Clin Pharmacol Ther 1984;35:733-741.
26. Holford NHG, Sheiner LB: Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981;6:429-453.
27. Ravel R: Clinical Laboratory Medicine. Chicago: Year Book Medical Publishers, 1984.
28. Duchin KL, Hutcheon PE: Distribution of intracortical renal blood flow induced by bumetanide in the dog. Clin Pharmacol Exp Ther 1978;204:135-140.
29. Marcantonio LA, Auld WHR, Skellern GG, Howes CA, Murdoch WR, Purohit R: The pharmacokinetics and pharmacodynamics of bumetanide in normal subjects. J Pharmacokinet Biopharm 1982;10:393-409.
30. Penttikäinen PJ, Neuvonen PJ, Kekki M, Penttilä A: Pharmacokinetics of intravenously administered bumetanide in man. J Pharmacokinet Biopharm 1980;8:219-228.
31. Martin SJ, Danziger LH: Continuous infusion of loop diuretics in the critically ill: a review of the literature. Crit Care Med 1994;22:1323-1329.
32. Kelly RA, Wilcox CS, Mitch WE, Meyer TW, Souney PF, Rayment CM, et al: Response of the kidney to furosemide. II. Effect of captopril on sodium balance. Kidney Int 1983;24:233-239.
33. Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, Souney PF: Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med 1983;102:450-458.
34. Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, et al: Na+, K+ and BP homeostasis in man during furosemide: effects of prazosin and captopril. Kidney Int 1987;31: 135-141.
35. Holland SD, Williamson HE: Probenecid inhibition of bumetanide-induced natriuresis in the dog. Proc Soc Exp Biol Med 1979;161:299-302.
36. Jacobsen HR, Kokko JP: Diuretics: sites and mechanisms of action. Annu Rev Pharmacol Toxicol 1976;16:201-214.
37. Kaojarern S, Day B, Brater DC: The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int 1982;22:69-74.